Trial Profile
Retrospective study of intravitreal aflibercept injections in treatment-naive patients with exudative age-related macular degeneration to assess the correlation between outer retinal layer and external limiting membrane changes with fluid response and visual improvement.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2015 New trial record